GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicus Pharma Ltd (OTCPK:MDPLF) » Definitions » EV-to-EBITDA

Medicus Pharma (Medicus Pharma) EV-to-EBITDA : -4.60 (As of May. 13, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Medicus Pharma EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Medicus Pharma's enterprise value is $27.83 Mil. Medicus Pharma's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $-6.05 Mil. Therefore, Medicus Pharma's EV-to-EBITDA for today is -4.60.

The historical rank and industry rank for Medicus Pharma's EV-to-EBITDA or its related term are showing as below:

MDPLF' s EV-to-EBITDA Range Over the Past 10 Years
Min: -10.4   Med: 0   Max: 0
Current: -4.67

MDPLF's EV-to-EBITDA is ranked worse than
100% of 704 companies
in the Drug Manufacturers industry
Industry Median: 14.705 vs MDPLF: -4.67

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-13), Medicus Pharma's stock price is $1.65. Medicus Pharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.420. Therefore, Medicus Pharma's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Medicus Pharma EV-to-EBITDA Historical Data

The historical data trend for Medicus Pharma's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicus Pharma EV-to-EBITDA Chart

Medicus Pharma Annual Data
Trend Dec21 Dec22 Dec23
EV-to-EBITDA
- - -3.70

Medicus Pharma Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only - - - - -3.70

Competitive Comparison of Medicus Pharma's EV-to-EBITDA

For the Drug Manufacturers - General subindustry, Medicus Pharma's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicus Pharma's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medicus Pharma's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Medicus Pharma's EV-to-EBITDA falls into.



Medicus Pharma EV-to-EBITDA Calculation

Medicus Pharma's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=27.833/-6.045
=-4.60

Medicus Pharma's current Enterprise Value is $27.83 Mil.
Medicus Pharma's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-6.05 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medicus Pharma  (OTCPK:MDPLF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Medicus Pharma's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.65/-0.420
=At Loss

Medicus Pharma's share price for today is $1.65.
Medicus Pharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.420.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Medicus Pharma EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Medicus Pharma's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Medicus Pharma (Medicus Pharma) Business Description

Comparable Companies
Traded in Other Exchanges
Address
100 King Street West, Suite 3400, One First Canadian Place, Toronto, ON, CAN, M5X 1A4
Medicus Pharma Ltd will carry on the business of pharmaceutical drug development focused initially on SkinJect. The objective of SkinJect is developing and commercializing novel microneedle arrays for the purpose of treating certain skin cancers, initially basal cell carcinoma.

Medicus Pharma (Medicus Pharma) Headlines

From GuruFocus

Medicus Pharma Opens the Market

By PRNewswire 10-26-2023